CRNACircio Holding ASA
9.180NOK+7.62%Mkt Cap: 235.51M $P/E:

Circio Holding ASA, a biotechnology company, develops novel circular RNA expression technology for gene and cell therapy. The company is developing TG01, a cancer vaccine targeting driver mutations, which is in three cli…

Key Statistics

Company
Market Cap235.51M $
Enterprise Value171.57M $
Revenue (TTM)
Gross Profit
Net Income (TTM)-4.29M $
Revenue/Share
Last Price9.180 NOK
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees8
CountryNO
SectorHealthcare
IndustryBiotechnology
ISINNO0013033795
Valuation
P/E (Trailing)
P/E (Forward)
PEG
EV/EBITDA-44.74
EV/Revenue
P/S
P/B-103.91
EPS (TTM)-0.43
EPS (Forward)0.00
52W Range
0.552062% of range14.46
52W High14.46 NOK
52W Low0.5520 NOK
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE367.49%
ROA-426.80%
Growth
Revenue Growth
Earnings Growth
Cash Flow & Leverage
Operating CF-4.28M $
CapEx (TTM)
FCF Margin
FCF Yield-1.10%
Net Debt209.86K $
Net Debt/EBITDA-0.05
Balance Sheet
Debt/Equity-0.67
Current Ratio0.46
Quick Ratio0.46
Book Value/Sh-0.0870 NOK
Cash/Share0.0280 NOK
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 NOK
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Splits
Last Split1:30
Split DateOct 4, 2023
Analyst Consensus
Rating
Target (Mean)
Target Range
# Analysts
Ownership
Shares Out.274.44M
Float168.58M
Insiders32.42%
Institutions3.74%
Technical
SMA 508.139 (+12.8%)
SMA 2005.338 (+72.0%)
Beta-1.17
S&P 52W Chg18.16%
Avg Vol (30d)4.24M
Avg Vol (10d)4.68M
Technical Indicators
RSI (14)49.7
MACD0.1386
MACD Signal0.1875
MACD Hist.-0.0489
BB Upper9.481 NOK
BB Middle8.759 NOK
BB Lower8.038 NOK
BB Width16.47%
ATR (14)0.5063 NOK
Vol Ratio (20d)1.00x